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491(a stent in which not all of the struts were inter-
connected, and the open areas between the struts
were >5 mm2), and 45 patients (38%) received a
closed-cell stent (interconnected struts and open
areas of #5 mm2). The proportion of patients who
showed new ischemic brain lesions on diffusion-
weighted magnetic resonance imaging (DWI) after
treatment did not differ between the former and the
latter groups (n ¼ 37 [50%] vs. n ¼ 22 [49%]), and
neither did the total number of new DWI lesions
when analyzed with a negative binomial regression
model (1).
However, in the long-term follow-up analysis of
the ICSS-MRI substudy (2), we observed a signal of
an increased risk of recurrent clinical cerebrovas-
cular events after the post-treatment magnetic
resonance imaging scan among patients treated with
open-cell stents compared with patients treated
with closed-cell stents; 15 patients in the former
group and 3 patients in the latter group experienced
a stroke or a transient ischemic attack up until the
end of available follow-up (hazard ratio: 3.09; 95%
conﬁdence interval: 0.89 to 10.7; p ¼ 0.075). This
observation supports the point made by Pacchioni
and colleagues that stent design may not only affect
the risk of periprocedural stroke, as has already
been shown in several studies (3,4), but also the risk
of delayed cerebrovascular events. Long-term data
from randomized controlled trials comparing stent-
ing versus endarterectomy for symptomatic carotid
stenosis have recently been pooled by the Carotid
Stenosis Trialists’ Collaboration and will provide
the basis for a more thorough examination of the
relationship between stent design and the occur-
rence of peri-procedural and delayed cerebrovas-
cular events (5).Henrik Gensicke, MD
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376:1062–73.Don’t Throw the Baby
Out With the Bath WaterWe read with interest the article by Uretsky et al. (1)
and would like to provide a few comments. The in-
vestigators did not describe if they included patients
with atrial ﬁbrillation and the number of cardiac cy-
cles used to assess mitral regurgitation (MR) by both
echocardiography and magnetic resonance imaging
(MRI) in such patients. In the presence of atrial
ﬁbrillation, variable RR intervals might affect both
echocardiography and MR calculations. With respect
to loading conditions, the overall group’s mean
values for blood pressure (BP) and heart rate (HR)
were comparable; however, the SD suggests that, for
an individual patient, BP and HR at the time of
echocardiography and MRI were likely not compara-
ble. It is also possible that MRI underestimated MR
volume in patients with mild aortic regurgitation
(AR), especially if AR was more than mild and
underestimated (we were not informed on how the
severity of AR was quantiﬁed). Table 4 shows that
patients with a progressive increase in MR severity as
seen by MRI had a progressive increase in left ven-
tricular (LV) end-diastolic diameter. LVEDD was
5.09  0.60 cm, 5.23  0.66 cm, and 6.11  0.59 cm,
respectively, and LV end-systolic diameter was
3.41  0.50 cm, 3.47  0.73 cm, and 4.07  0.53 cm,
respectively, in mild, moderate, and severe MR by
MRI. Because MR severity was calculated using LV
end-diastolic volume (EDV), the higher the LVEDV,
the more severe the MR according to MRI. Therefore,
in the presence of normal LV size (and EDV), MRI is
likely to underestimate MR severity. In addition, pa-
tients with higher LVEDVs are expected to have a
greater reduction in LVEDV post-MR surgery than
those with a normal LVEDV. Thus, instead of
concluding that MRI is a better method to assess MR
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492severity, the study showed that increased LV volumes
pre-MR surgery predicted recovery of LVEDV post-
MR surgery. Careful assessment of MR by using
comprehensive echocardiographic methodology in
studies with similar (2) or a larger sample size and
blinded core laboratory assessment (3) showed LV
reverse remodeling after percutaneous mitral valve
repair, which indicates that echocardiography is able
to select appropriate surgical candidates by quanti-
fying MR accurately. Figure 2 shows a patient in
whom MR was quantiﬁed as severe by echocardiog-
raphy and mild by MRI. LV enlargement, posterior
leaﬂet prolapse, and color Doppler suggest more than
mild MR. Reverse remodeling post-surgery in this
patient indicates appropriate echocardiography MR
assessment.
The study also had a small sample size of 26 pa-
tients because 7 were not yet due for follow-up.
Transesophageal echocardiography (TEE) was per-
formed in only 37% of study patients. It remains
unclear if the agreement in 37 patients between
echocardiography and MRI was based on trans-
thoracic echocardiography or TEE, and how many
TEEs were included in the subset of 93 patients in
whom variability of MR severity was assessed. TEE
allows a more comprehensive assessment of the
mitral valve and MR. The wide scatter in agreement
for MR between readers 1 and 2 might be related to
varying reader expertise and/or comprehensiveness
and the quality of echocardiography studies. Finally,
some of the nuances of MRI post-processing, notably
whether the papillary muscles and/or LV trabecula-
tions were included in ventricular volume tracings
(which could affect LV volume quantiﬁcation [4])
were incompletely described.*Tasneem Z. Naqvi, MD
Michael B. Gotway, MD
*Mayo Clinic
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First Do No HarmWe thank Drs. Naqvi and Gotway for their comments,
and offer the following point-by-point response:
1. Our study (1) included 5 (5%) patients with atrial
ﬁbrillation at imaging. Agreement between mag-
netic resonance imaging (MRI) and echocardiog-
raphy was not adversely affected. Speciﬁcally,
concordance between MRI and echocardiography
was 40% in patients with atrial ﬁbrillation and 37%
in patients in sinus rhythm.
2. The “large” SDs of blood pressures merely reﬂects
the range of blood pressures in our patients. A
paired Student t test showed no statistically sig-
niﬁcant difference at the time of echocardiography
and MRI. Furthermore, as noted in the Discussion
section, the strong correlation shown in Figure 4A
would not be possible if variability of afterload was
an important consideration.
3. If aortic regurgitation were underestimated by
MRI, it would lead to an overestimation of mitral
regurgitant volume, not an underestimation.
4. We do not believe our study shows that pre-
surgical left ventricular (LV) volumes predict
recovery of LV end-diastolic volume (EDV) post-
surgery. For example, in Table 4, patient 29 had
mild mitral regurgitation (MR) and an end-diastolic
diameter (EDD) of 6.2 cm, whereas patient 38 had
severe MR and an EDD of 5.3 cm. Our study shows
that MR volume (determined as the difference
between LV stroke volume and forward ﬂow)
strongly correlates with the decrease in LVEDV
following surgery (Figure 4A).
5. We do not believe studies showing reverse
remodeling following percutaneous repair indicate
that echocardiography selects appropriate surgical
candidates. The bar graph shown in our Central
Illustration conﬁrms that echocardiography can be
used to predict the degree of remodeling.
However, it does a much poorer job than MRI. As a
result, many patients are incorrectly classiﬁed as
having severe MR, potentially leading to inappro-
priate surgical intervention (Figure 3).
6. We do not believe any amount of negative remodeling
following surgery indicates an appropriate surgical
candidate. MRI-derived ventricular volumes increase
even in patients with mild MR (2). The fact that MRI
